  See all
 |
Articles: Pharmacoeconomics |
Prior Articles
Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines
Current Medical Research and Opinion, 09/29/09
The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values
PharmacoEconomics, 09/28/09 Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors
Current Medical Research and Opinion, 09/24/09 Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
PharmacoEconomics, 09/23/09 The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
PharmacoEconomics, 09/22/09 Head Lice Treatments and School Policies in the US in an Era of Emerging Resistance: A Cost-Effectiveness Analysis
PharmacoEconomics, 09/22/09 Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus Infection
Journal of the American Society of Nephrology, 09/21/09 A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
PharmacoEconomics, 09/18/09 Methods for Measuring Temporary Health States for Cost-Utility Analyses
PharmacoEconomics, 09/18/09 Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
PharmacoEconomics, 09/18/09 Determinants of Willingness to Pay for a New Therapy in a Sample of Menopausal-Aged Women
PharmacoEconomics, 09/14/09 Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation
Drugs & Aging, 09/14/09 The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
PharmacoEconomics, 09/11/09 The need and total cost of Finnish eyecare services: a simulation model for 2005-2040
Acta Ophthalmologica, 09/11/09 Economic Burden of Follicular Non-Hodgkins Lymphoma
PharmacoEconomics, 09/10/09 Faiz Kermani Where will the economic crisis leave pharma and biotech
Pharmaceutical Technology, 09/09/09
Free full text
A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes
PharmacoEconomics, 09/03/09 Estimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations
PharmacoEconomics, 09/02/09 Case-Control Studies in Pharmacoeconomic Research: An Overview
PharmacoEconomics, 09/02/09 Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada
Pharmacoepidemiology and Drug Safety, 09/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
153 Available Pages
|
|
